Based on the in vitro results, the in vivo proliferation suppressive effect of RAC3 depletion was determined in a xenograft tumor model by subcutaneous injection of 5637-shNC/shRAC3 cells (Figure 3E). This evidence concerns the gene RAC3 and neoplasm.